dr. pinato discusses intra-tumor heterogeneity in primary and metastatic hcc
Published 7 years ago • 211 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
2:44
intra-tumor heterogeneity in primary and metastatic hcc
-
2:02
dr. pinato on study of immune-tolerogenic pathways in primary and metastatic hcc
-
1:57
dr. pinato on pd-l1 testing in hcc
-
3:15
dr. pinato on molecular characterization of tumor microenvironment in nets
-
4:55
the complexities of hepatocellular carcinoma
-
5:40
multitargeted tki therapy in metastatic hcc
-
1:33
dr. ramaswamy discusses tumor heterogeneity
-
59:11
understanding phenotypic plasticity in hepatocellular carcinoma to mitigate therapy resistance
-
1:09
dr. petricoin on tumor heterogeneity and signaling architecture
-
4:24
second-line tivantinib (arq 197) in met-high hepatocellular carcinoma (metiv-hcc study)
-
7:30
progress in the management of hepatocellular carcinoma
-
1:38
dr. pinato discusses pheochromocytomas and paragangliomas
-
1:06
impact of genomic testing: theodoros teknos, md
-
1:15
dr. tripathy discusses iniparib trial heterogeneity
-
1:35
dr. jun discusses cyptogenic hepatocellular carcinoma
-
0:47
ask dr. keith unger: can proton therapy be used on brain tumors?
-
0:26
dr. peter zavitsanos explains the difference between a ct scan and a pet scan
-
34:53
clinical implications and intratumour heterogeneity charles swanton, frcp, ph.d.
-
1:19
dr. greten discusses the impact of the gut microbiome on liver tumors